Puran Chen

Huddinge, AB 14157, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns.

Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns.

Journal: International journal of molecular sciences
Published: November 28, 2025

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Journal: EBioMedicine
Published: November 12, 2025

Alpha-toxin-elicited CX3CL1 release in Staphylococcus aureus pneumonia impairs bactericidal function of human monocytes.

Alpha-toxin-elicited CX3CL1 release in Staphylococcus aureus pneumonia impairs bactericidal function of human monocytes.

Journal: mBio
Published: October 13, 2025

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.

Journal: Clinical & translational immunology
Published: July 01, 2025

Dysregulated Adaptive Immune Responses to SARS-CoV-2 in Immunocompromised Individuals.

Dysregulated Adaptive Immune Responses to SARS-CoV-2 in Immunocompromised Individuals.

Journal: Microorganisms
Published: March 14, 2025

The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.

The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.

Journal: Genes and immunity
Published: July 04, 2024

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Journal: EBioMedicine
Published: May 01, 2024

Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV.

Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV.

Journal: Scientific reports
Published: March 18, 2024

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.

Journal: Cell host & microbe
Published: November 06, 2023

Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.

Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.

Journal: The Journal of infectious diseases
Published: September 05, 2023

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states.

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states.

Journal: Science translational medicine
Published: July 12, 2023

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia.

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia.

Journal: Journal of hematology
Published: May 14, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026